Position in RCUS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,933,280
+$2,676,517 QoQ
Shares Held
135,800
+687.5% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $252,934,314 across 133 Biotechnology names. RCUS ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
206,675 | $15,519,225 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
291,488 | $11,726,562 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
507,828 | $11,050,335 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
497,365 | $10,663,505 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
504,143 | $10,561,795 | |
| 6 | LEGN |
Legend Biotech Corp
|
516,633 | $9,345,890 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
155,776 | $9,058,374 | |
| 8 | BNTX |
BioNTech SE
|
79,189 | $7,038,317 |
All Filings in RCUS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,933,280 | 135,800 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $256,763 | 17,244 | Shares | Defined | 2025-02-13 | |
| 2024-03-31 | $607,746 | 32,190 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $1,298,235 | 63,921 | Shares | Sole | 2023-08-07 | |
| 2021-12-31 | $395,918 | 9,783 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $450,639 | 17,359 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $345,113 | 20,135 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||